Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
With
Procter and Gamble
Age
65–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Symptoms of OAB for at least six months prior to Visit 3
Symptoms of OAB during the 7 day diary period immediately preceding Visit 3:
≥ 1 UUIE on average per day and
≥ 10 episodes of micturition on average per day
You may not be if
A total daily urinary volume \> 3000 ml or a mean volume voided per micturition of \> 300 ml as verified in the micturition diary before randomization
Post-void residual (PVR) urinary volume \> 100 ml
Clinically significant stress urinary incontinence as determined by the investigator
Clinically significant bladder outlet obstruction as determined by the investigator
Concomitant diseases in which the use of anticholinergic drugs is contraindicated, e.g. urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, myasthenia gravis, severe hepatic impairment (Child Pugh B and C), severe ulcerative colitis, toxic megacolon.
Clareo Health | Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder
